3 - Secondary Haemostasis

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/15

encourage image

There's no tags or description

Looks like no tags are added yet.

16 Terms

1
New cards

Types of components in coagulation

• Zymogens - inactive enzyme that becomes active following specific proteolytic cleavage e.g. factors 7, 9, 10, 11 and 2 (prothrombin)

• Cofactors - help enzymes work efficiently e.g. factors 5, 8 and 3 (tissue factor)

• Substrate - protein acted upon to produce a new product e.g. fibrinogen (F1)

• Calcium - factor 4 (Ca2+) helps coagulation factors bind to suitable phospholipid surfaces and assemble complexes

• Transglutaminase - forms covalent bonds that stabilise fibrin e.g. factor 13a

2
New cards

Factor groups

• Prothrombin group - 2, 7, 9 and 10 plus protein C and S (vitamin K dependant)

• Fibrinogen group - fibrinogen (1), 5, 7 and 13 (acted upon by thrombin)

• Contact group - 11, 12, prekallikrein and HMWK - participate in contact activation and interact with kinin, complement and fibrinolytic systems

3
New cards

Extrinsic pathway

• Tissue factor (cofactor) binds to circulating F7 and its activated form F7a

• The TF-F7a complex, in the presence of calcium, activates F10 to F10a

• The complex also activates F9, feeding into the intrinsic tenase pathway and amplifying the response

4
New cards

Intrinsic pathway

• F12 is activated to F12a through contact activation (interaction with certain negatively charged surfaces)

• F12a activates F11 to F11a

• F11a activates F9 to F9a in the presence of calcium

• F9a combines with activated F8a (cofactor), calcium and negatively charged phospholipid surface on activated platelets to form the intrinsic tenase complex

• The tenase complex activated F10 to F10a

5
New cards

Kallikrein and HMWK

• F12 also activates prekallikrein into kallikrein which amplifies F12 activation

• HMWK is a cofactor for contact activation

• F12 can prolong the APTT but is not associated with increased bleeding tendency

• F13 deficiency can cause bleeding despite normal PT and APTT as these tests do not directly measure the final cross-linking step

6
New cards

Common pathway

• F10a combines with F5a (cofactor), calcium and a suitable phospholipid surface to form the prothrombinase complex

• Prothrombin (F2) is converted to thrombin (F2a)

• Thrombin converts fibrinogen (F1) into fibrin

• Thrombin also activates F13 to F13a, which cross-links fibrin

7
New cards

Cell based coagulation model

• Better explains how coagulation occurs in vivo, emphasises TF as the physiological trigger and the platelet surface reactions as the source of the thrombin burst

• Initial phase - tissue factor exposed on TF-bearing cells, small initial amount of thrombin produced

• Amplification phase - thrombin activated several targets, platelets become activated and expose the phospholipid surface, FV (also released from platelet granules) is activated to FVa, F8 is activated to F8a

• Propagation (thrombin burst) - the activated platelet surface now brings the essential components together

• Intrinsic tenase - F9a + F8a + calcium + phospholipid

• Prothrombinase - F10a + F5a + calcium + phospholipid

8
New cards

Haemophelia

• Haemophilia A - F8 deficiency

• Haemophilia B - F9 deficiency

• Haemophilia C - F11 deficiency, severity is variable

9
New cards

Vitamin K dependant factors

• Vitamin K is needed for the post-translational modification called gamma-carboxylation of certain glutamate residues in coagulation proteins

• This modification allows these proteins to bind calcium and attach to negatively charged phospholipid surfaces

• Without vitamin K these proteins may still be produced but have an impaired function

• Warfarin is a vitamin K antagonist

10
New cards
11
New cards
12
New cards
13
New cards
14
New cards
15
New cards
16
New cards